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A B S  T R A  C T  The effects of the two local anesthetics tetracaine and procaine and a 
quaternary amine derivative of lidocaine,  QX314,  on sarcoplasmic reticulum  (SR) 
Ca  2+  release  have  been  examined  by  incorporating  the  purified  rabbit  skeletal 
muscle  Ca  2+  release  channel  complex  into  planar  lipid  bilayers.  Recordings  of 
potassium ion currents through single channels showed that Ca  2÷- and ATP-gated 
channel activity was reduced by the addition  of the tertiary amines tetracaine and 
procaine to the c/s (cytoplasmic side of SR membrane) or tram (SR lumenal) side of 
the  bilayer.  Channel  open  probability  was  lowered  twofold  at  tetracaine  and 
procaine concentrations  of ~  150  tzM and 4  raM, respectively.  Hill coefficients of 
2.0 and greater indicated that the two drugs inhibited channel activity by binding to 
two  or  more  cooperatively  interacting  sites.  Unitary  conductance  of  the  K +- 
conducting  channel  was  not  changed  by  1  mM  tetracaine  in  the  c/s  and  trans 
chambers. In contrast, c/s millimolar concentrations of the quaternary amine QX314 
induced  a  fast blocking effect at  positive  holding potentials without  an apparent 
change  in  channel  open  probability.  A  voltage-dependent  block was  observed  at 
high concentrations (millimolar) of tetracaine, procaine, and QX314 in the presence 
of 2  ~M ryanodine which induced  the formation of a  long open subconductance. 
Vesicle-4~Ca  2+ ion flux measurements also indicated an inhibition of the SR Ca  9+ 
release  channel  by  tetracaine  and  procaine.  These  results  indicate  that  local 
anesthetics  bind  to two or more  cooperatively interacting  high-affinity regulatory 
sites  of  the  Ca  2+  release  channel  in  or  close  to  the  SR  membrane.  Voltage- 
dependent blockade of the channel by QX314 in the absence of ryanodine, and by 
QX314,  procaine  and  tetracaine  in  the  presence  of  ryanodine,  indicated  one 
low-affinity site within the conduction pathway of the channel.  Our results further 
suggest that  tetracaine  and  procaine  may primarily  inhibit  excitation-contraction 
coupling in skeletal muscle by binding to the high-affinity, regulatory sites of the SR 
Ca  2+ release channel. 
INTRODUCTION 
In  skeletal  muscle,  the  release  of calcium  ions  from  the  intracellular  membrane 
compartment,  sarcoplasmic reticulum  (SR),  is  triggered  by an action  potential  that 
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originates at the neuromuscular synapse and spreads rapidly over the muscle surface 
and  into the  cell  interior through invaginations, the  transverse  tubule  (T-tubule) 
(Ebashi,  1976; Stephenson,  1981). The electrical  excitatory signal is thought to be 
communicated from  the  T-tubule  to  the  SR  at junctional locations where  large 
protein structures span the narrow gap separating the two membranes (Peachey and 
Franzini-Armstrong,  1983). These  structures  have  been  variously  termed  "feet" 
(Franzini-Armstrong,  1970), "bridges"  (Somlyo,  1979), "pillars"  (Eisenberg  and 
Eisenberg,  1982), or "spanning proteins" (Caswell and Brandt,  1989), and are now 
believed to  be  identical with the  ligand-gated, ryanodine-sensitive "Ca  2+  release" 
channel of SR (for reviews see Fleischer and Inui, 1989; Lai and Meissner,  1989; but 
see also Zaidi, Lagenaur, Hilker, Xiong, Abramson, and Salama,  1989). The specific 
mechanism of signal transduction from the T-tubule to SR, commonly referred to as 
excitation-contraction (E-C) coupling, remains  to be  fully defined, however.  One 
postulated mechanism is that T-tubule depolarization increases  the concentration of 
a chemical messenger such as Ca  2+ (Endo,  1977; Fabiato,  1983) or IPs (Donaldson, 
Goldberg, Walseth,  and Huetteman,  1988; but see  also Walker,  Somlyo, Goldman, 
Somlyo,  and Trentham,  1987) in the junctional gap,  which  then opens the Ca  ~+ 
release channel in the SR membrane. Another mechanism, the mechanical coupling 
mechanism, suggests that small transient charge movements observed during T-tu- 
bule depolarization may represent the physiological link between T-tubule depolar- 
ization and  SR  Ca  2+  release  (Schneider,  1981). An  important implication of the 
mechanical coupling model is that the SR Ca  2+ release channel is in direct contact 
with  a  voltage-sensing molecule  in  the  T-tubule  membrane.  Recent  biophysical, 
pharmacological, and  molecular biological  evidence has  suggested  that  the  dihy- 
dropyridine (DHP)  receptor may be the voltage sensor in E-C coupling in skeletal 
muscle (Rios and Pizarro,  1988; Tanabe, Beam, Powell, and Numa, 1988). 
The  two local  anesthetics procaine and tetracaine have been used to study the 
mechanism of E-C coupling in amphibian (Liittgau and Oetliker, 1968; Almers and 
Best,  1976; Hui,  1983; Vergara  and  Caputo,  1983; Csernoch,  Huang, Szucs, and 
Kovacs, 1988) and mammalian (Lamb, 1986) skeletal  muscle.  Studies with intact or 
cut (Almers  and Best,  1976; Hui,  1983; Vergara and Caputo,  1983), and skinned 
(Ford and Podolsky,  1972; Thorens and Endo,  1975; Donaldson et al.,  1988; Pike, 
Abramson,  and  Salama,  1989) fibers  as  well  as  isolated  membrane  preparations 
(Nagasaki  and Kasai, 1981; Kirino and Shimizu,  1982; Morii and Tonomura, 1983; 
Antoniu, Kim, Morii, and Ikemoto, 1985; Ohnishi,  1987; Palade,  1987; Pike et al., 
1989) have indicated that tetracaine and procaine inhibit the release of Ca  2+ from 
SR. In most studies a relatively high procaine concentration of 10 mM was used to 
inhibit SR Ca  2+ release.  In contrast, tetracaine concentrations as low as  10-50  ~,M 
were  found  in  some  studies  to  affect  SR  Ca  ~+  release  (Csernoch  et  al.,  1988; 
Nasri-Sebdani,  Traore,  Cognard,  Potreau,  Poindessault, and  Raymond,  1990), al- 
though in general, concentrations > 100 I~M were required to more fully inhibit the 
SR Ca  2+ release pathway. Interpretation of the studies using elevated concentrations 
of tetracaine is complicated because tetracaine, in addition to inhibiting SR Ca  ~+ 
release, appears to influence T-tubule charge movement (Huang,  1982; Hui,  1983; 
Csernoch et al.,  1988; Pizarro,  Csernoch, Uribe, Rodriguez, and Rios,  1991; Szucs, 
Csernoch,  Magyar,  and  Kovacs,  1991). Additional  local  anesthetics  reported  to Xu ~T ~.  SR Ca  2+ Release Channel and Local Anesthetics  209 
inhibit  45Ca2+ release from isolated  SR include  the  neutral  local anesthetic  benzo- 
caine,  other  tertiary  amines  such  as lidocaine  or  dibucaine,  and  QX314,  a  water- 
soluble quaternary  amine derivative of lidocaine  (Volpe, Palade,  Costello,  Mitchell, 
and Fleischer,  1983;  Fernandez-Belda,  Soler, and Gomez-Fernandez,  1989). 
In this report we have more directly studied the interaction of the SR Ca  z+ release 
channel with the two local anesthetics tetracaine and procaine, as well as QX314, by 
reconstituting  the  purified  30S  rabbit skeletal muscle channel complex into planar 
lipid bilayers. The reconstituted Ca  z+ release channel conducted monovalent cations 
and Ca  2+  ions, was activated by Ca  2+  and ATP,  and was modified by ryanodine  as 
previously reported (Smith, Coronado, and Meissner,  1986; Lai, Erickson, Rousseau, 
Liu, and Meissner,  1988; Smith, Imagawa, Ma, Fill,  Campbell, and Coronado,  1988). 
Tetracaine  and  procaine  primarily inhibited  the  Ca  2+- and ATP-gated  channel  by 
reducing channel open probability (Po).  In contrast,  QX314  reduced single channel 
conductance without a noticeable effect on channel Po. An inhibition of the SR Ca  2+ 
release  channel  by  micromolar  tetracaine  and  millimolar  procaine,  but  not  by 
millimolar QX314, was also observed using SR vesicle fractions passively loaded with 
45Ca2+" 
Some of these results have been communicated in part in abstract form (Xu, Jones, 
and Meissner,  1990). 
EXPERIMENTAL  PROCEDURES 
Materials 
Tetracaine and procaine were obtained from Sigma Chemical Co.  (St. Louis, MO), ryanodine 
was from AgriSystems  International (Wind  Gap,  PA), 45Ca~+ was from ICN Pharmaceuticals 
(Irvine, CA), and phospholipids were from Avanti Polar Lipids, Inc. (Birmingham, AL). QX314 
was the generous gift of Dr. Bertil Takman (Astra Pharmaceutical Products, Westborough, MA). 
All other reagents were of analytical  grade. 
Isolation  of SR  Vesicles and the 30S Ca  2+ Release  Channel Complex 
"Heavy" rabbit  skeletal  muscle SR vesicles were prepared  in  the  presence of the  protease 
inhibitors  diisopropylfluorophosphate  (DIFP;  1  mM)  and  leupeptin  (1  I~M) as  described 
previously (Meissner,  1984). Briefly, SR vesicles containing the SR Ca  ~+ release channel were 
recovered from the 36--42% region of sucrose  gradients that contained membranes sediment- 
ing at 2,600-35,000 g. The 30S Ca  2+ release channel complex was purified by sucrose density 
gradient  centrifugation  after  solubilization  of  heavy  SR  vesicles  in  the  presence  of the 
zwitterionic detergent CHAPS as previously described (Lai et al.,  1988). SDS gel electrophoresis 
showed  the presence of a single  high molecular weight protein in Ca  2+ release channel peak 
fractions.  This suggested that minimal proteolysis of Ca  2+ release channel polypeptides had 
occurred during purification. 
45Ca2+ Flux Measurements with Passively  Loaded  Vesicles 
45Ca2+ efflux  rates from vesicles passively loaded with  45Ca2+ were  determined by filtration 
(Meissner,  1984). Unless otherwise indicated,  45Ca~+ was equilibrated across vesicle membranes 
(10 mg of protein/ml) by incubation for 2 h at 23°C in a medium containing 20 mM KPipes, 
pH 7, 100 mM KCI, 0.1 mM EGTA, 1.1 mM 45Ca2+, 5 p.M leupeptin, and 1 mM DIFP. 45Ca2+ 
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containing  varying concentrations of free Ca  2+, AMP, ATP, Mg  2+, and local anesthetics. 45Ca2+ 
efflux was terminated by the addition of a quench solution (10 mM Mg  2+, 1 mM EGTA, and 10 
I-LM ruthenium red, final concentrations) and washing of vesicles with the quench solution on 
0.45  Ixm  HAWP  filters  (Millipore  Corp.,  Bedford,  MA)  to  separate  away untrapped  and 
released 45Ca2+. Radioactivity retained by the vesicles on the filters was determined by liquid 
scintillation counting. 45CaZ+ efflux measurements were carried out at least in duplicate using 
two or more preparations. Standard deviations were _+ 15% or less. 
Planar Lipid Bilayer Measurements 
Single channel measurements were performed by incorporation of the purified rabbit skeletal 
muscle  30S  Ca  2+  release  channel complex  into  Mueller-Rudin planar bilayers containing 
phosphatidylethanolamine, phosphatidylserine, and phosphatidylcholine in the ratio 5:3:2 (50 
mg/ml phospholipid in n-decane; Lai et al.,  1988).  Unless otherwise indicated, a symmetrical 
solution of buffered KCI (0.25 M KC1, 20 mM KPipes, pH 7) was used to record single channel 
currents. Small aliquots (1-3 1~1) of the 30S gradient fractions were added to the c/s chamber 
(defined as the SR cytoplasmic side; Miller,  1978) of the planar lipid bilayer apparatus. Both 
chambers were briefly stirred (10-15  s) after the addition of local anesthetics. In perfusion 
experiments, local anesthetics were removed by perfusing the chamber containing the local 
anesthetic with 3---4  vol of a drug-free solution for ~ 7 min with the use of a Harvard perfusion 
pump. The purified ryanodine receptor exhibits multiple conductance states  when reconsti- 
tuted into the planar bilayer (Lai et al.,  1988;  Ma,  Fill, Knudson, Campbell, and Coronado, 
1988;  Smith et al.,  1988;  Liu, Lai,  Rousseau, Jones,  and Meissner,  1989).  In this study we 
examined only the fully conducting channel state (770 pS with 250 mM K  +) since this state was 
seen in a majority ( ~ 80%) of our single channel recordings. The electrical signals were filtered 
at 4  kHz for storage on videotape using a modified audio processor and videotape recorder 
(Bezanilla,  1985).  Unless  otherwise  indicated,  current recordings were  filtered  at  600  Hz 
through an eight-pole, low-pass Bessel filter (model 902-LPF; Frequency Devices Inc., Haver- 
hill,  MA)  and digitized at  2.0  kHz for analysis using a  Dell  200 AT-clone computer and a 
modified version of a program kindly provided by Dr.  H. Affolter.  Po values were calculated 
from the digitized data using a single threshold level set at 50% of the current amplitude (Smith 
et al.,  1986). The Po values and "diary" plots were determined from data stored in two and five 
to six 17-s files, respectively.  All recordings in this study lasted at least half an hour. 
Biochemical Assays 
Protein was determined by the method of Kaplan and Pederson (1985) using Amido Black and 
0.45-1~M filters (type HA;  Millipore Corp.).  Bovine serum albumin was used as  the  protein 
calibration standard. Free Ca  ~+ concentrations were calculated using a computer program and 
the binding constants published by Fabiato (1981).  H + concentration measurements with a pH 
electrode in media containing 0.1 and 0.25 M KC! indicated for tetracaine a pKa of 8.5 and 8.6, 
respectively, in good agreement with a reported pKa of 8.5 (Courtney, 1980). 
RESULTS 
Vesicle 45Ca2+ Flux Measurements 
The three compounds used in this study differ in several respects in their physico- 
chemical properties.  Tetracaine and  procaine are  tertiary  amines that  are  largely 
protonated  at  pH  7  in aqueous  medium (Courtney,  1980,  and  our  Experimental 
Procedures). However, an important difference is that tetracaine is a more hydropho- XU ET AL.  SR Ca  2+ Release Channel and Local Anesthetics  211 
bic and membrane-soluble compound than procaine, as indicated by an oleylalcohol/ 
water  partition  coefficient  of 80  as  compared with  0.6  for  procaine  (Covino  and 
Vassallo,  1976).  QX314  is  a  quaternary  amine with  a  very  low  oleylalcohol/water 
partition coefficient (Hille,  1977). 
Fig.  1 illustrates the effects of tetracaine on the time course of 45Ca~+ release from 
heavy SR Ca  ~+ release vesicles. The vesicles were initially passively loaded with 1 mM 
45Ca2+ and then diluted into release media that either inhibited or partially activated 
the SR Ca  2+ release channel. As previously observed (Meissner,  1984), 45Ca  2+ release 
was  slow  in  a  medium  containing  the  two  Ca  2+  release  inhibitors  Mg  2+  and 
ruthenium red. Addition of 500 tzM tetracaine to the Ca  ~+ release-inhibiting medium 
did  not  appreciably  affect  the  45Ca~+ efflux  behavior of the  vesicles  (not  shown). 
When vesicles were placed in a medium containing  10 tzM free Ca  2+, which partially 
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FIGUi~  1.  Tetracaine  inhibition  of 
45Ca2+ efflux  from heavy SR vesicles. 
SR vesicles were passively loaded with 
1  mM  45Ca2+ and  diluted  200-fold 
into release media containing 20 mM 
KPipes, pH 7, 0.1  M KCI, and either 
10 mM Mg  ~+, 10 p.M ruthenium red, 
and 1 mM EGTA ([5]), or 10 ~M free 
Ca  ~+  (100  p,M  EGTA and  105  p,M 
Ca  2+)  (O)  plus  25  (0),  100  (A),  or 
500  (A)  ~M tetracaine. 45Ca2+ efflux 
rates were determined as described in 
Experimental Procedures.  Data from 
one  representative  experiment  are 
shown. 
activates the Ca  2+ release channel (Smith et al.,  1986), a majority of vesicles released 
their  45Ca2+ contents  in  < 30  s.  Some radioactivity  remained with  the  vesicles for 
longer times, indicating the presence of a small subpopulation of vesicles lacking the 
Ca  2+ release channel (Meissner,  1984). Addition of 25 and  100 p,M tetracaine to the 
10  I~M  Ca  2÷  medium  noticeably  reduced  the  4~Ca2+ efflux  rate.  At  500  IzM 
tetracaine, 45Ca2+ efflux rates approached those measured in the presence of 10 mM 
Mg  2+ and  10 IxM ruthenium red. Accordingly, elevated concentrations of tetracaine 
appeared to almost fully inhibit the Ca~+-activated SR Ca  ~÷ release channel. 
The rate of 45Ca2+ efflux from heavy SR vesicles is dependent on the composition 
of the release medium, such as free Ca  2+,  Mg  2+, and adenine nucleotide concentra- 
tion, or pH (Meissner,  1984; Meissner, Darling, and Eveleth,  1986). Fig. 2 shows that 
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ttM free Ca  2+, 1 mM Mg  ~+, and 5 mM AMP yielded half-times of 4SCa  2+ release of 10 
and  11  s,  respectively.  In  both  release  media,  tetracaine was  similarly effective in 
inhibiting 45Ca2+ efflux. Half-times of 45Ca2+ efflux increased to  ~ 20 and  100  s in 
the presence of 50 and 500 p.M tetracaine, respectively. A nearly complete inhibition 
of 45Ca2+  release  by  500  ttM  tetracaine  was  also  observed when  the  Ca  2+  release 
channel was activated by placing vesicles into release media containing  <  10 -s M free 
Ca  2+  plus  2.5  mM ATP or  10  IxM free  Ca  2+,  8  mM  Mg  2+,  and  6  mM  adenosine 
5'(13,~/-methylene)triphosphate (AMP-PCP) (not shown). 
Tetracaine is a tertiary amine (pKa 8.5 in 0.1  M KCI; see Experimental Procedures) 
that  is  ~ 97%  protonated  at  pH  7.  The  inhibitory  effects  of the  protonated  and 
uncharged forms of tetracaine were tested by measuring 45Ca2+ efflux at pH 7.8 and 
6.8, which changes  the extent of protonation  to 80 and 98%,  respectively. Vesicles 
were  diluted  into  release  media  containing  20  o.M  free  Ca  2+,  5  mM  AMP,  and 
millimolar Mg  2+. The concentration of Mg  2+ was adjusted to 5 mM (at pH 7.8) and  1 
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FIGURE 2.  Dependence  of 
45Ca2+  ef~Elx on tetracaine con- 
centration.  SR  vesicles  were 
passively  loaded  with  5  mM 
45Ca  2+  and  diluted  100-fold 
into  release  media  containing 
20  mM  KPipes,  pH  7,  0.1  M 
KC1, the  indicated  concentra- 
tions  of tetracaine,  and  either 
125  p,M  free  Ca  ~+  (100  I~M 
EGTA, 225 p.M Ca  2+) (O) or 20 
p~M free Ca  ~+ (100  p,M EGTA, 
115 IxM Ca  2+) plus 5 mM AMP 
and  1  mM,  Mg  z+  (~7).  The 
45Ca~+  efflux  half-times  of the  Ca~+-permeable  vesicle  fraction  are  shown.  Data  of  two 
representative experiments are shown. 
mM  (at  pH  6.8)  to  obtain  similar  half-times  of  45Ca2+  efflux  (10  and  15  s, 
respectively).  In  both  release  media,  the  addition  of  100  p~M  tetracaine  nearly 
doubled  the  half-time  of 45Ca2+ effiux  (not  shown).  This  result  suggests  that  the 
efficacy of tetracaine in inhibiting SR Ca  2+ release activity was not appreciably altered 
by a  10-fold change in the concentration of the uncharged form of tetracaine (20 and 
2  p~M at pH 7.8 and 6.8, respectively). 
The effects of procaine and QX314 on the 45Ca2+ release behavior of SR vesicles 
were  studied  following  the  procedure  described  in  Fig.  1 by diluting  vesicles into 
release media containing  10 p,M free Ca  2+ and millimolar concentrations of the two 
compounds. The half-time of 45Ca2+ efflux was doubled in the presence of 2.5  +-  1.0 
mM procaine (n =  3; Table I). A similar efficacy of procaine inhibition was observed 
in release media that contained  < 10 -8 M free Ca  ~+ plus 0.5  mM ATP or  10 or  100 
p,M free Ca  2+. This result suggested that the effectiveness of procaine in inhibiting 
the  SR  Ca  ~+  release  channel  was  not  significantly  altered  when  the  channel  was XU ET AL.  SR Ca  z+ Release Channel and Local Anesthetics  213 
activated by either ATP (Meissner et al.,  1986) or Ca  2+. Preincubation  of vesicles with 
1-10 mM procaine for 2  h  at 23°C, followed by dilution into release media containing 
the same procaine concentration,  did not increase the efficacy of procaine inhibition. 
In  other  experiments,  vesicles  were  incubated  with  10  mM  procaine  or  500  ~M 
tetracaine  and  local  anesthetics  were  then  removed  by  washing  of vesicles  before 
passive  loading  with  1  mM  45Ca2+.  Restoration  of  full  45Ca~+  release  activity 
TABLE  1 
Kinetic Parameters  of SR Ca  z+ Release Channel Inhibition and Blockade 
Parameter  Tetracaine  Procaine  QX314 
Inhibidon of 4sCa2+ effiux 
Lso (mM) 
Inhibition of single channel activity 
L~,0 (raM) 
Single channel blockade 
0.10 -  0.05 (n = 4)  2.5 ±  1.0 (n = 3)  Not observed 
0.15 ± 0.05 (n =  11)  4.0 -+ 2.5 (n =  14)  Not observed 
0.6 -+ 0.2 (n = 8)  > I0 (n = 4) 
-  Ryanodine 
kbo (mM -I ms -I)  4.4 -  0.2 
Vbo (mY)  -72.4 -+ 6.4 
k-bo (ms -I)  54.4 -+ 4.0 
V-bo (mV)  28.8 -+ 2.8 
KDo (mM)  13.2 +- 0.7 
V~ (mV)  19.7 ±  1.1 
+ Ryanodine 
kbo (mM -I ms -l)  0.83 ~ 0.14  0.13 ~ 0.01 
Vbo (mV)  -35.6 ± 4.2  -32.0 -+ 2.1 
k-bo (ms -I)  27.7 ± 8.9  7.2 ± 0.5 
V-bo (mV)  -197 +_ 288  24.7 ±  1.5 
KDo (raM)  33.4 +_ 0.1  55.4 -+ 6.2 
VDo (mV)  43.4 _  0.1  14.2 --+ 3.3 
L~0 indicates  the local anesthetic concentration that resulted in half-maximal reduction of 4SCa2+ efflux rates 
and  channel  open  probabilities.  Derived parameters  of single  channel  blockade  were  obtained  from 
continuous recordings by analysis of current amplitude distributions  of local anesthetics  as described  in the 
text. Closed channel contributions to current amplitude histograms  were removed as described by Yellen 
(1984) and Quayle et al. (1988). 
suggested  that  the  two  local  anesthetics  inhibited  SR  Ca  2+  release  in  a  reversible 
manner.  Addition of 5  mM QX314  to the  10 ~M Ca  ~+ release medium  did not result 
in  a  noticeable  inhibition  of  45Ca2+  release  regardless  of  whether  vesicles  were 
passively  loaded  with  45Ca2+  for  2  h  in  the  presence  or absence  of 5  mM  QX314. 
These  results  suggest  that  the  order of effectiveness in inhibiting Ca  2÷  release  from 
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Single Channel Measurements with Tetracaine 
The  effects  of tetracaine  on  the  SR  Ca  ~+  release  channel  were  also  more  directly 
visualized by incorporating purified, CHAPS-solubilized channels into Mueller-Rudin 
planar lipid bilayers. The  reconstituted  SR Ca  2÷  release channel  does not  conduct 
anions such as CI-, and it conducts monovalent cations more efficiently than it does 
Ca  ~+  (Lai  et  al.,  1988;  Smith  et  al.,  1988).  Accordingly,  channel  activity can  be 
conveniently  monitored  in  a  monovalent  cation  medium.  In  a  majority  of  our 
recordings,  single  channel  activity was  greatly  reduced  and  often  irreversibly lost 
when  either positive or negative membrane  potentials of magnitude  > 60  mV were 
applied to the bilayers for several minutes. The effects of tetracaine on single channel 
activity were therefore examined only in the relatively narrow voltage range of -60  to 
+60  mV.  For  membrane  potentials  ranging  from  -20  to  +20  mV,  tetracaine 
inhibition of channel activity was largely independent of holding potential. Outside of 
this  range,  variable  effects  were  observed.  In  some  recordings,  tetracaine  nearly 
equally inhibited channel  activity for both  negative and  positive membrane  poten- 
tials, whereas  in  other experiments  the  inhibitory action was  more evident on  one 
side of the reversal potential (Erev) than on the other side. 
The  purified  channels  were  inserted  into  the  bilayers  in  the  presence  of  a 
symmetric 0.25  M  KC1,  20 mM KPipes, pH 7 medium (Fig. 3). In the upper trace of 
Fig. 3 A, the channel was activated by 100 o,M Ca  2+ in the c/s chamber (the side of the 
Figure  3. (opposite)  Effect of tetracaine on single channel activity of the purified Ca  2+ release 
channel complex. (A) Single channel currents, shown as downward deflections (c, closed), were 
recorded in symmetrical 0.25  M KCI media containing 100  I~M free Ca  2+ c/s (100 I~M EGTA, 
200 p.M Ca  2+) and 6 ~M free Ca  2+ trans (100 tzM EGTA, 100  p,M Ca2+). Holding potential = 
10 mV. Bars beside each trace indicate the level of the closed state. (Top trace) In the absence of 
tetracaine, Po  =  0.55. (Middle trace) With 200 ~M tetracaine cis, Po =  0.21. (Bottom trace) With 
500 ~M tetracaine c/s, Po =  0.05. (B) Single channel currents, shown as downward deflections, 
in symmetrical 0.25 M KCI media containing 9 t~M free Ca  ~+ plus 2.4 mM ATP c/s and 50 p.M 
free Ca  2+ trans. HP =  + 19 inV. (Top trace) With no tetracaine, Po =  0.88. (Middle trace) With 200 
~M  tetracaine trans, Po  =  0.38.  (Bottom trace) With 500  IxM tetracaine trans, Po  =  0.12.  (C) 
Currents,  shown as upward deflections, in symmetrical 0.25  M KC1 media containing 50  t~M 
free Ca  z+ c/s and trans. HP -= -25 inV. (Top trace) Without tetracaine, Po =  0.49. (Middle trace) 
With 200  trM  tetracaine trans, Po =  O. 11. (Bottom trace) After perfusion of trans chamber with 
0.25 M KCI medium containing 50 I~M free Ca  ~+, Po =  0.48. (D) Diary plot of the experiment 
in C. Shown are values of Po as fractional open times during successive sweeps of 250 ms. (1) 
Control without tetracaine (105 s), (2) after addition of 200 p,M tetracaine trans (105 s), and (3) 
after perfusion (90 s). The two gaps between 1 and 2,  and 2  and 3 correspond to periods of 
stirring  and  perfusion,  respectively.  (E)  Dependence  of Ca  2+  release  channel  activity  on 
tetracaine concentration.  Relative fractional channel open  times (PJPo) were obtained from 
single channel recordings similar to those shown in A (O), and B (A). Solid lines were obtained 
according to the equation 
Px/Po =  [l +  ([T]/KD)nn] -1 
where T  is the indicated tetracaine concentration, and using dissociation constants (KD) of 170 
~M (C)) and  180  I~M (A) and Hill coefficients (nil) of 2.5 and 2.2, respectively. Xu ET AL.  SR Ca  2+ Release  Channel and Local Anesthetics  215 
A 
Control 
+200  ~M Tetracaine  els 
B 
Control 
+200  ~M Tetracaine  trens 
+500 ~M Tetracaine cis  +500 ~M Tetracaine trans 
4  pA  10  p£ 
280  me  280  ms 
C 
Control 
+200  ~M  Tetracaine  trans 
After  perfusion  trans  ~.~ 
o  --  /  10  pA 
~)  220  ml 
o..I"'tl!i   " 
0.0  ~  i 
0  100  200  800  700 
Time  (s) 
E 
1.0 
0.8 
0.6 
0.4 
0.2 
0.0  I  I 
0  250  500 
Tetracaine  (~M) 
FIGURE 3. 216  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  101  •  1993 
bilayer to which the channel was added; c/~ and trans chambers correspond to the SR 
cytoplasmic  and  lumenal  sides,  respectively  [Miller,  1978;  Smith  et  al.,  1986]). 
Channel activity was  greatly reduced upon the addition of c/s tetracaine. The drug 
reduced the Po of the Ca2+-activated channel from 0.55 to 0.21 and 0.05 at 200 and 
500  p,M  tetracaine,  respectively. At  500  I~M, channel  openings were  inhibited  for 
prolonged intervals without an apparent change in single channel conductance (772 
pS  in  0.25  M  K+;  see  below).  Current  traces  of a  Ca  ~+-  and  ATP-activated  Ca 2+ 
release  channel  in  Fig.  3 B  show  a  similar  inhibition  of  channel  activity  when 
tetracaine is added to the trarg,  rather than the c/s, side of the bilayer. In the absence 
of tetracaine (upper trace of Fig.  3 B), the channel displayed prolonged periods of 
channel openings resulting in a  nearly optimally activated channel.  Channel open- 
ings were only occasionally interrupted by periods of silent channel activity lasting 
> 50 ms. The addition of 200 and 500 p,M tetracaine trans decreased channel open 
probability from 0.88 to 0.38 and  0.12,  respectively. Again,  tetracaine induced the 
formation of long closed channel intervals that were disrupted by periods of rapid 
channel openings and closings. 
Reversibility of channel inhibition by tetracaine was  tested in  six experiments by 
recording  channel  activity  before  and  after  the  addition  of tetracaine,  and  after 
removal of the drug by perfusion.  In four of these experiments, the bilayer broke 
during the prolonged (~ 7 min) perfusion step. In the two remaining experiments, 
one of which is shown in Fig.  3, C and D,  a  nearly complete restoration of channel 
activity was observed after removal of the drug. This result suggested that tetracaine 
reversibly inhibited the channel, as observed in 45Ca2+ flux measurements. 
Tetracaine concentrations needed  for a  twofold reduction of channel Po ranged 
from 75  to  750  IxM  (n =  19).  In  11  of 19  experiments,  tetracaine  concentrations 
comparable to those observed in vesicle-45Ca  2+ flux experiments (Figs.  1 and 2) were 
effective in  reducing channel Po twofold, with  a  mean  tetracaine  concentration of 
(150 -+ 50) p,M (Fig. 3 E). A twofold decrease in Po was observed with either 150 IxM 
cis  or trans  tetracaine  for channels  that were  activated by either micromolar Ca  2+ 
(n =  6) (Fig. 3A) or micromolar Ca  2+ plus mM ATP (n =  4) (Fig. 3 B), or that were 
recorded  in  the  presence of 50  p.M  free  Ca  2+  and  millimolar ATP  and  Mg  2+  cis 
(n =  1) (not shown). In other experiments (8 of 19), higher levels of tetracaine with a 
mean concentration of 600 -+ 200 I~M were required to effect a twofold reduction of 
channel Po (not shown). An average Hill coefficient of 2.5  +  0.4  (n =  3)  (Fig.  3 E) 
suggests  that  the  SR Ca 2+  release  channel  contains  interacting inhibitory binding 
sites for tetracaine. 
In  Fig.  4A,  the  current-voltage  relationships  of a  single  channel,  recorded  in 
symmetric 0.25 M KC1, 20 mM KPipes, pH 7, buffer, are plotted in the presence and 
absence of tetracaine. A slope conductance of 772 -+ 43 pS (n =  47) was obtained for 
the K + conducting release channel; the conductance remained essentially unchanged 
after the  addition  of 500  p~M  tetracaine cis  (Fig.  4 A)  or trans  (not shown),  or the 
addition of 500 p,M or 1 mM tetracaine to both sides of the bilayer (not shown). The 
effects of tetracaine on single channel conductance were also tested in the presence of 
10  mM  Ca  ~+  trarg  (Fig.  4B).  Addition  of  10  mM  Ca  2+  to  the  trans  chamber 
significantly reduced single channel currents at negative holding potentials and, to a 
lesser extent, at positive voltages. The reversal potential (Erev) was shifted to +5 mV, 
from which, by applying constant field theory, a permeability ratio of Ca  2+ over K + Xu ET AL.  SR Ca  2+ Release Channel and Local Anesthetics  217 
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FIGURE 4.  Current-voltage relation- 
ships  of K+-conducting  Ca  2+  release 
channel.  (A)  Single channel  currents 
were recorded in symmetrical 0.25  M 
KCI media containing 9  o,M free Ca  2+ 
plus 2.4 mM ATP c/s and  6  o~M free 
Ca  2+  tram,  in  the  absence  (O)  and 
presence ([-1) of 500 ~M tetracaine c/s. 
Data from one representative experi- 
ment  are  shown.  TK  +  =  740  pS.  (B) 
Currents  were recorded  in symmetri- 
cal 0.25  M  KCI media containing  15 
o,M  free  Ca  ~+  plus  1.2  mM  ATP  c/s 
and  50  v,M (O) or  10  mM  (V)  Ca  2+ 
trans, and with 10 mM Ca  ~+ tram and 
500  v,M  tetracaine  c/s  and  trans  (0). 
Standard  deviations were equal  to or 
smaller  than  the  size of the  symbols 
(n =  4). 
Holding  Potential  (mV) 
ions (Pca/PK) of 3.8 was calculated, in accordance with previous measurements (Smith 
et  al.,  1988;  Liu  et  al.,  1989).  Tetracaine  augmented  the  effects  of trans  Ca 2+  by 
shifting E~v to slightly more positive values, suggesting a possible modification of the 
permeability  behavior  of the  channel,  and  also by  further reducing  single  channel 
current  values,  particularly  at  positive  holding  potentials.  The  effects  on  these 218  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  101  •  1993 
current values were essentially the same when tetracaine was added either to the c/s or 
trans  chamber  or  to  both  chambers  simultaneously. The  efficacy  of  tetracaine  in 
decreasing channel Po in the presence of 10 mM Ca  2+ trans was comparable to  that 
observed in the absence of millimolar Ca  2+ trans  (Fig. 3). 
Single  Channel Measurements  with Procaine 
In agreement  with  vesicle-45Ca  2+  flux  measurements,  millimolar concentrations of 
procaine were required to noticeably reduce SR Ca  z+ release channel activity. In Fig. 
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FIOURE 5.  Effect of procaine on single channel activity of Ca  2+  release  channel. (A)  Single 
channel currents,  shown  on  the  left  as  downward  deflections  (c,  closed),  were  recorded  in 
symmetrical 0.25 M KCI media containing 9 ~M free Ca  2+ plus 2.4 mM ATP cis and 50 I~M free 
Ca  2÷ trans.  Holding potential =  20 inV. (Top trace) Without procaine, Po  =  0.84. (Second trace) 
With 3 mM procaine cis, Po  =  0.33.  (Third trace) With 6 mM procaine c/s, Po  =  0.11. (Fourth 
trace) With  10 mM procaine cis, Po  =  0.03.  (B) Currents, shown as downward deflections, in 
symmetrical 0.25 KCI media containing 9  I~M free Ca  ~+ and 2.4 mM ATP cis and 50 I~M free 
Ca  2+ trans.  Holding potential =  25 mV. (Top trace) Without procaine, Po  =  0.35. (Middle  trace) 
With 6 mM procaine cis, Po =  0.06. (Bottom trace) After perfusion ofcis chamber for 10 min with 
0.25 M KCI medium containing 9  o~M free Ca  z+ and 2.4 mM ATP, Po =  0.86.  (C) Diary plot 
Ca  2+ of the experiment in B. Shown are values of Po as fractional open times during successive 
sweeps of 250 ms. (1)  Control before addition of procaine (105 s), (2)  after addition of 6  mM 
procaine cis (105 s), and (3) after perfusion (90 s). The two gaps between 1 and 2,  and 2 and 3 
correspond to periods of stirring and perfusion, respectively. Xu ET AL.  SR Ca  2+ Release Channel and Local  Anesthetics  219 
5 A,  the open probability of a  Ca  2+- and ATP-activated channel was reduced from 
0.84  to  0.33,  0.11,  and  0.03,  respectively, by  the  addition  of 3,  6,  and  10  mM 
procaine  to  the  c/s  chamber.  A  Hill  coefficient of 2.2  +  0.1  (n =  2)  of procaine 
inhibition again suggested an allosteric inhibition of SR Ca  2+ release channel activity 
by local anesthetics. In 14 of 18 experiments, procaine concentrations comparable to 
those obtained in vesicle-45Ca  2+  flux studies (Table I) were effective in reducing Po 
twofold, with a mean concentration of (4 -+ 2.5) mM procaine. The decrease in Po was 
observed with c/s (12 of 14 experiments) and trans  (2 of 4 experiments) procaine for 
channels  that  were  activated  by  ~  10  ~M  Ca  2+  in  the  presence of 2-3  mM  ATP 
(n =  12), or by 100 I~M Ca  2+ in the presence and absence of 5 mM AMP (n =  2). In 
six  (of six)  experiments  procaine  nearly  equally  reduced  channel  Po  at  holding 
potentials of -20  and  +20  inV.  In the remaining experiments (4 of 18),  procaine 
concentrations ranging from 5 to 15 mM were ineffective or only marginally effective 
in  reducing channel  Po  (not  shown).  In  two  of these,  we  observed  a  pronounced 
voltage-dependent reduction in apparent single channel currents; however, because 
of its infrequent occurrence this phenomenon was not further studied. 
Reversibility of inhibition of single channel activity by procaine was  tested in  11 
experiments. In three of these, the bilayer broke during the perfusion step. In one 
experiment,  a  twofold  reduction  in  the  unitary  conductance  of the  channel  was 
observed after perfusion. In two experiments, no channel activity could be observed 
after perfusion.  In  the remaining  five experiments, Po either increased  (n =  3)  or 
decreased (n =  2) up to  ~ 2.5-fold after perfusion when compared with Po values in 
the control condition. Fig. 5, B and C show an experiment in which Po increased after 
the perfusion step. Addition of 6 mM procaine c/s reduced the Po of the Ca  2+- and 
ATP-activated channel from 0.35 to 0.06. After removal of the drug by perfusion of 
the c/s chamber with a 0.25 M KCI medium, Po increased to 0.86. 
Single Channel Recordings  with QX314 
The quaternary amine QX314 did not noticeably affect single channel conductance 
and Po at all holding potentials when added to the trans  chamber at concentrations 
ranging from 2 to 10 mM (not shown). In contrast, a pronounced voltage-dependent 
reduction in single channel currents was apparent at positive holding potentials in six 
of six experiments when QX314 was  added  to the c/s chamber (Fig.  6).  No major 
reduction  in  current  amplitude  was  observed  upon  return  to  negative  holding 
potentials. Reduction in current amplitude could be also fully reversed by perfusion 
of the cis chamber with a QX314-free solution (n =  1; not shown). 
Block of Ryanodine-modified  Ca  2+ Release Channel 
The neutral  plant  alkaloid ryanodine induces in  single channel recordings a  long- 
lived subconductance  state of the SR Ca  2+  release channel  (upper trace of Fig.  7; 
Rousseau,  Smith,  and  Meissner,  1987;  Smith  et  al.,  1988;  Liu  et  al.,  1989).  The 
ryanodine-modified channel state is largely insensitive to subsequent addition of c/s 
Ca  2+, ATP, or Mg  2+, physiological regulators that otherwise greatly affect the gating 
behavior  of the  channel.  Ryanodine  modification  also  rendered  the  channel  less 
sensitive to inhibition by tetracaine, since addition of 1 mM tetracaine to both sides of 220  THE JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  101  • 1993 
the bilayer reduced channel Po only minimally at negative holding potentials (from 
~ 1 to 0.97-0.99,  n  =  4;  not shown). At positive holding  potentials,  tetracaine was 
somewhat  more  effective  in  causing  partial  channel  closing.  At  +60  mV,  Po was 
lowered from  ~  1 to values ranging from 0.97  to 0.55  (n =  4).  A  second  effect of 
tetracaine was to reduce single channel conductances at positive holding potentials in 
a voltage-dependent manner. In the presence of I mM tetracaine on both sides of the 
bilayer, the current values were reduced at +60 mV by 25 +- 13% (n =  7; second and 
third traces of Fig.  7). A  similar reduction was observed when 2  mM tetracaine was 
added to either side of the bilayer (not shown), indicating that the effect was caused 
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FIGURE 6.  Single channel recordings in the presence of QX314.  Single channel currents were 
recorded in symmetrical 0.25 M KCI media containing 16.5 wM free Ca  2+, 2.4 mM ATP, 0, 2, 
or 5 mM QX314 c/s, and  100 p.M free Ca  2+ tram.  Holding potential =  18 (left traces) and 38 
(right traces) mV. 
by the  total concentration  of the  drug  that was present  in  the  system. At negative 
holding  potentials,  the  current values of the ryanodine-modified channel were not 
altered by the presence of up to 2 mM tetracaine in either the c/s or trans chamber. 
We  also  found  that  c/s  procaine  reduced  the  conductance  of  the  ryanodine- 
modified  channel  (fourth  trace  of Fig.  7;  n  =  3).  This block was  only observed at 
positive voltages and was voltage dependent (not shown). Addition of QX314 to the 
cis chamber induced a flickery block of the ryanodine-modified channel (bottom trace 
of Fig.  7;  n  =  3).  As  observed  for the  ryanodine-unmodified  channel,  addition  of 
QX314  to  the  tram  chamber  did  not  affect  the  gating  and  conductance  of the 
ryanodine-modified channel at negative or positive holding potentials (n =  3). XU ET AL.  SR Ca  2+ Release Channel and Local Anesthetics  221 
Analysis  of Block of Ca  ~+ Release Channel by Local Anesthetics 
Experiments  with  QX314  (Fig.  6)  and  the  ryanodine-modified  channel  (Fig.  7) 
indicated  that  local  anesthetics  may  inhibit  SR  Ca  ~+  release  by  a  direct  blocking 
mechanism. The interaction of a blocking ion (B) with the open state of the channel 
can be illustrated by the following reaction: 
kb 
Ro+ B~Re 
k_b 
+8  /~  Ryanodine,  HP-20  mV 
HP==60  mV 
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FIGURE 7.  Effects  of local an- 
esthetics  on  the  ryanodine- 
modified SR Ca  ~+ release chan- 
nel.  Single  channel  currents 
were  recorded  in  symmetrical 
0.25  M  KCI media  containing 
50 ~.M free Ca  2+. The top trace 
shows a  sudden change in  the 
gating and conductance behav- 
ior of the channel ~ 4 min after 
the addition  of 2 I~M ryanodine 
c/~.  Po  increased  from  0.1  to 
nearly  1, whereas  single  chan- 
nel  conductance  decreased 
from 750 to 400 pS. Also shown 
are  single  channel  recordings 
of  the  ryanodine-modified 
channel  at +60 mV before (sec- 
ond trace) and after the addition 
of 1 mM tetracaine c/s and tram 
(third trace), 10 mM procaine c/s 
(fourth  trace),  and  10  mM 
QX314  cis  (fifth  trace).  Traces 
1-3,  4,  and 5  show three sepa- 
rate experiments. 
where Ro is the open channel state,  RB is the blocked channel state,  and kb and k-b 
are  the  blocking  and  unblocking  rates,  respectively.  The  appearance  of  single 
channel  recordings  produced  by  the  action  of channel  blockers  depends  on  the 
length of time that the channel is in state RB and the time resolution of the recording 
system (Yellen,  1984). If the action of the channel blocker is very fast, such that the 
duration of the blocking events is  too short to be resolved, only the  time-averaged 
current between the open (Ro) and the blocked (RB) states is measured, leading to an 
apparent reduction in the recorded channel current. Such an action is considered to 
be  a  fast  blocking process.  A  slow  blocking  process,  on  the  other  hand,  contains 222  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  101  •  1993 
blocking  events  that  last  long  enough  to  be  fairly well  resolved  by the  recording 
system. Finally, an intermediate or flickery blocker produces events long enough  to 
be  detected  by  the  system  but  not  long  enough  to  be  well  resolved.  Current 
amplitude  histograms produced  by the  action  of fast blockers show  a  single  sharp 
peak  corresponding  to  the  time-averaged  current,  while  those  generated  by  slow 
blockers show two clearly resolved peaks corresponding to the current amplitudes of 
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FIGURE  8.  Current amplitude histograms of ryanodine-modified channel in the presence of 2 
and  10 mM QX314.  Current amplitude histograms were constructed from recordings (top of 
each panel)  at a  low (1  Hz), intermediate  (50  Hz), and high  (t,000  Hz) bandwidth  of the 
recording system. Holding potential =  +47 mV. Current in the absence of QX314 (Io) =  21.0 
pA. Ordinate gives number of occurrences per 17 s (at 1 and 50 Hz) and 7 s (at  1 kHz) files. 
Abscissa represents  the  relative  current  amplitude, with  0 and  1 corresponding to baseline 
current and open channel amplitude without QX314,  respectively.  The solid lines in the two 
middle panels were calculated  according to Eq. 2 and using the following model parameters at 
2 and 10 mM QX314 cis,  respectively: a  =  4.83 and 4.05, b =  3.47 and 26.04. 
the blocked and the unblocked  (open) channels (Yellen,  1984).  Intermediate block- 
ing  processes  yield  broad  current  amplitude  distributions;  if  the  blocking  and 
unblocking rates are markedly different,  these distributions  may be skewed (Yellen, 
1984). 
The blocking action of QX314 on the ryanodine-modified channel was analyzed as 
a  fast, intermediate, or slow blocking process by varying the filter setting to change 
the bandwidth of the recording system. Fig. 8 shows the apparent current recordings Xu ET AL.  SR Ca  2+ Release Channel and Local Anesthetics  223 
and current  amplitude histograms produced  by the ryanodine-modified channel in 
the presence of 2 and 10 mM QX314 c/s at filter settings of 1, 50, and 1,000 Hz. At 1 
Hz, no discrete channel  transitions were observed. The current amplitude distribu- 
tions were narrow with a  single peak characteristic of a  fast blocking process (upper 
two panels). Such a channel blockade can be described by 
IB  1 
I o -  1  +  [B]/K D  (l) 
where  IB  is  the  time-averaged  single  channel  current  produced  by  the  blocking 
process,  Io is  the  current  recorded  in  the  absence  of the  blocking  ion,  [B]  is  the 
concentration  of the blocking ion,  and KD is the dissociation constant. Values of IB 
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FIGURE 9.  Current-voltage relations 
of ryanodine-modified channel in the 
presence  of QX314.  Shown  are  the 
apparent current-voltage relations of 
K+-conducting,  ryanodine-modified 
channel in the absence ((3) and pres- 
ence of 2 (~7), 5 (A), and  10 mM (V) 
QX314 cis. Filter  =  1 Hz. Data were 
fitted  according  to  Eq.  1 using  de- 
rived parameters shown in Table I. 
measured  in  the  presence  of  QX314  varied  in  a  concentration-  and  voltage- 
dependent  manner  (Fig.  9),  indicating  that  the  derived  KD  values  were  voltage 
dependent at positive holding potentials (see below). 
At a  filter setting of 50  Hz, indistinct  channel  transitions were apparent  (middle 
two panels of Fig. 8). The current amplitude distributions were broadened, indicative 
of an intermediate blocking process. These amplitude histograms were well fitted by 
distributions  described  by  the  following  probability  distribution  function  (Yellen, 
1984): 
f(y) = ya-l(1  -  y)b-t/B(a, b)  (2) 
where y is the current amplitude of the filter output, a  (= air) and b (= 13x) are model 
parameters  dependent  on  %  the  effective  time  constant  of the  filter  at  the  given 
frequency setting, and B(a, b) is a beta function defined by 
B(a, b) =  f01 ya-l(1 -y)b-1 dy  (3) 224  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  101  •  1993 
The blocking (kb) and unblocking  (k-b) rates and the dissociation  constant  (KD) were 
obtained from the parameters a  and  ~  using 
k b =  p/[B]  (4) 
k-b =  a  (5) 
KD = k-b/kb  (6) 
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FIGURE 10.  Derived parameters of analysis of QX314 blockade of ryanodine-modified chan- 
nel. Blocking ([~, kb) and unblocking (a) parameters were obtained from a fitted beta function 
(Fig. 8) using an effective time constant (~) of 0.228/f, where f is 3-db attentuation frequency of 
the Bessel filter. In A, holding potentials were  17 (©), 27 (A), 37 (F-l), 47 (V), and 57 (&) mV. 
In B, c/s QX314 concentrations were 2 (C)), 5 (~7), and  10 (A) mM. In D, dissociation constants 
were obtained from recordings filtered at 1 (V), 50 (O), and  1,000 ([[]) Hz, as described in the 
text. Standard deviations were equal to or smaller than symbols. 
Values ofa  =  4.83  and 4.05  and b  =  3.47  and  26.04 were obtained at 2 and  10 mM 
QX314 c/s,  respectively, by fitting Eqs.  2  and  3  to the  amplitude  distributions  of the 
middle  panels  of  Fig.  8  using  the  nonlinear  least-squares  routines.  At  holding 
potentials ranging from + 17 to +57 mV, the blocking parameter [3 increased linearly 
with  QX314  concentration  (Fig.  IOA),  whereas  the  unblocking  parameter  ~  was 
independent  of [QX314]  (Fig.  10 B).  Both parameters,  as well as the derived values 
of kb,  k-b,  and  KD,  were  voltage  dependent  at  positive  holding  potentials,  varying Xu ET ~a..  SR Ca  z+ Release Channel and Local Anesthetics  225 
linearly with the voltage in the semilogarithmic plots of Fig.  10, B-D. Such a voltage 
dependence can be described by an equation of the form 
X = Xo exp (-V/Vxo)  (7) 
where X represents the given parameter, Xo is the apparent zero-voltage value of the 
parameter,  and  Vxo is  a  quantity associated with the parameter  that describes  the 
voltage dependence of the block. The derived values of k~, k-bo, KDo, Vbo, V-bo, and 
VDo for the QX314 block of the ryanodine-modified channel are listed in Table I. Fig. 
10 D shows that essentially identical KD/voltage relations were obtained when QX314 
was analyzed as a  fast (at  1 Hz), intermediate (at 50 Hz), or slow (at  1,000 Hz, see 
below) blocker. 
At  1,000  Hz,  the  current  amplitude  histogram  produced  by  the  ryanodine- 
modified channel in the presence of 2 mM QX314 contained peaks corresponding to 
the  current  amplitudes  of the  blocked  and  unblocked  (open)  channel  (lower left 
panel  of Fig.  8),  indicating that  the  block  could  be  analyzed as  a  slow  blocking 
process at this frequency. Such a blocking process can be analyzed using the following 
equation: 
PB  1 
Po -  1 +  [B]/KI)  (8) 
where PB and Po are the channel open probability in the presence and absence of the 
blocker, respectively, and [B] and KD have the same meaning as in Eq.  1. Channel 
Po's  were  determined  using  a  single  threshold  level  set  at  50%  of the  current 
amplitude obtained in the absence of QX314.  Under these conditions, the KD values 
exhibited  a  voltage  dependence  of  the  form  described  in  Eq.  7;  the  derived 
KD/voltage relation was essentially identical to those obtained by analyzing QX314 
block as a fast and as an intermediate blocking process (Fig. 10 D; Table I). At 10 mM 
QX314, blockage was still too fast to yield fully resolved unblocked channel events at 
1,000 Hz (lower right panel of Fig. 8). 
The blocking actions of QX314 on the ryanodine-unmodified channel (Fig. 6) and 
of procaine  on  the  ryanodine-modified channel  (Fig.  7)  were  also  analyzed  as 
intermediate processes by fitting measured amplitude histograms to a beta function 
(Table  I).  Since blocking and unblocking rates were  appreciably faster than those 
observed  for the  QX314  block of the ryanodine-modified channel  (Fig.  7),  single 
channel currents were analyzed at a filter setting of 1,000 Hz. Analysis of procaine as 
a fast blocker of the ryanodine-modified channel at a filter setting of 10 Hz yielded 
V~ values that were essentially identical to, and KDo values that differed by no more 
than a factor of two from, the values obtained in the intermediate blocking analysis 
listed in Table I. The voltage-dependent block of the ryanodine-modified channel by 
tetracaine could be described as an intermediate blocking process since at 1 kHz the 
current histograms could be fitted to a beta function. However, a strong dependence 
of the unblocking parameter ct on tetracaine concentration, and a nonlinear depen- 
dence  of  the  blocking  parameter  {3  on  tetracainc  concentration  indicated  that 
tetracaine  did  not  block  the  ryanodine-modified channel  by  a  simple  blocking 
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DISCUSSION 
Previous studies  have  suggested  that  the local anesthetics  tetracaine and  procaine 
inhibit  the  release  of Ca  ~+  ions  from  SR.  The  4~Ca2+ release  flux  measurements 
presented here confirm the inhibitory effects of tetracaine and procaine on SR 45Ca2+ 
release.  The  efficacy of tetracaine  and  procaine  in  inhibiting  SR  45Ca2+  release 
correlated with  their  oleylalcohol/water partition  coefficients. While  45Ca2+ efflux 
rates  from  passively  loaded  SR  vesicles  in  the  presence  of  500  izM  tetracaine 
approached  those  measured  in  the  presence  of  the  SR  Ca  2+  release  channel 
inhibitors  Mg  ~+  and  ruthenium  red,  procaine concentrations in  excess of 10  mM 
were required to nearly fully inhibit SR 45Ca~+ release. The efficacy of this inhibition 
by tetracaine and procaine was similar under different channel activating conditions, 
and  was  not  appreciably  altered  by a  10-fold change  in  the  concentration of the 
uncharged  form  of tetracaine.  QX314,  a  highly  water-soluble,  quaternary  amine 
derivative of lidocaine, had no noticeable effect on vesicle flux measurements at a 
concentration of 5 mM. 
Single channel measurements provided more detailed insights into the effects of 
local anesthetics on the SR Ca  ~+ release channel. We found that the channel can be 
inhibited  by  two  different mechanisms  as  exemplified by  the  action  of the  lipid- 
soluble, tertiary amine tetracaine and the water-soluble, quaternary amine QX314 on 
the  ryanodine-unmodified and  -modified channel,  respectively. The results  of this 
study can be readily explained by postulating that the two drugs inhibited SR Ca  2+ 
release by binding to two or more high-affinity regulatory sites located in or near the 
SR membrane and one low-affinity blocking site within the conduction pathway of the 
channel,  respectively. The  presence  of multiple  drug  binding  sites  has  been  also 
postulated  for  the  tetrodotoxin-sensitive Na +  channel  (Khodorov,  Shishkova,  Pe- 
ganov, and Revenko, 1976; Moczydlowski, Uehara, and Hall, 1986; but see also Hille, 
1977). 
AUosteric Inhibition of Ryanodine-unmodified Channel by Tetracaine and Procaine 
Inhibition of Ca2+-gated channel activity by tetracaine and procaine was character- 
ized by a lack of voltage dependence and membrane sidedness. These two observa- 
tions are difficult to explain by a traditional blocking mechanism and instead suggest 
that the two local anesthetics inhibited channel activity by binding to a regulatory site 
that  resides  in  or  close  to  the  bilayer.  A  Hill  coefficient of  ~ 2.5  suggested  the 
presence of two or more cooperatively interacting drug binding sites whose occupa- 
tion resulted in an aUosteric modulation of the channel's structure and function. 
In some experiments, lower tetracaine and procaine concentrations were ineffec- 
tive  in  appreciably  inhibiting  channel  activity.  One  possible  explanation  is  a  de- 
creased binding  affinity of the regulatory sites for local anesthetics in some of the 
channels, which may have occurred during purification and reconstitution. We do not 
believe that channels with a lower affinity for tetracaine or procaine are typical of SR 
channels since the efficacy of tetracaine and procaine inhibition in vesicle 4SCa2+ flux 
experiments matched that of the higher, and not lower, affinity channels. 
The effects of tetracaine on the Ca  2+ release channel were more complex in the 
presence  of millimolar  Ca  z+  on  the  trans  side  of the  bilayer.  We  found  that,  in Xu ET AI..  SR Ca  e+ Release Channel and Local Anesthetics  227 
addition to the gating, the conductance of the channel was modified. In the presence 
of 10  mM Ca  2+  trans  but  in  the  absence  of tetracaine,  the  reversal  potential was 
shifted to  positive values  and  the  K + conductance of the  channel was  decreased. 
Reduction  of  K +  conductance  was  greater  at  negative  than  at  positive  holding 
potentials. Since at negative voltages the current-carrying cations (K  +, Ca  2+) move 
from the trans  (SR lumenal) side to the c/s (SR cytoplasmic) side, this suggests that 
Ca  ~+  reduced  the  rate  of K ÷  passage  through  the  channel  by  interacting  more 
strongly than K ÷ with site(s)  within the ion conductance pathway. The addition of 
tetracaine to either side of the bilayer reduced Po and shifted Erev to more positive 
values, resulting in an increase of the calculated permeability ratio Pca2+ /PK+ from 
3.8  to 6.8.  Single channel current values were reduced more for positive than for 
negative voltages, partially offsetting the asymmetry in conductance induced by trans 
millimolar Ca  2+. Further experiments are needed to ascertain the properties of the 
asymmetric block of K + conductance by Ca  ~+  before modification of this block by 
tetracaine can be studied in more detail. 
Inhibition of Ca2+-gated Ca  z+ release channel activity by procaine resembled that 
of tetracaine; however, several quantitative differences were noted. One was that in a 
majority of bilayer experiments a  much higher concentration (~ 25  times greater) 
was needed for procaine to reduce channel Po twofold (Table I). Second, procaine 
rarely induced the formation of very long closed events (~" >  200 ms). Consequently, 
long  closed  intervals,  interspersed  by  bursts  of rapid  channel  activity, were  only 
infrequently seen in the presence of procaine. Third, procaine occasionally induced a 
fast-blocking effect on the conductance of the ryanodine-unmodified channel without 
an apparent change in channel open time. Some of the differences in the action of 
procaine and tetracaine on SR Ca  9+  release channel activity may be related to the 
more  hydrophobic  character  of  tetracaine.  Although  steric  considerations  may 
explain the differences in the action of the two local anesthetics, it is conceivable that 
tetracaine, by binding with higher affinity, dissociates less readily from hydrophobic 
binding sites, thereby inducing more substantial alterations in channel structure and 
function. 
Single Channel Blockade  by QX314 
In  contrast  to  tetracaine  and  procaine,  QX314  did  not  inhibit  SR  Ca  ~+  release 
channel  activity by  an  allosteric  mechanism.  Rather,  effects  of QX314  could  be 
described by a  traditional blocking mechanism in that single channel blockade was 
dependent on drug concentration and membrane potential, and was only observed 
when QX314 was added to the c/s (SR cytoplasmic) side of the bilayer. As predicted 
from a simple theory of channel blockade (Woodhull, 1973), blocking and unblocking 
rates of QX314  had an opposite voltage dependence, although of different magni- 
tude,  and  thereby both contributed to  the voltage dependence of the dissociation 
constant of QX314  binding.  Dissociation constants and their voltage dependences 
were obtained by analyzing current records of single ryanodine-modified channels at 
three  filter settings.  Essentially identical KD values and voltage dependences were 
obtained,  increasing  our  confidence  in  our  data  analysis.  One  interpretation  of 
empirically derived voltage parameters has been provided by the single ion blocking 
model of Woodhull (1973). Applying the derived equation VDo =  RT/z~F, where ~ is 228  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  101  •  1993 
the fraction of the membrane field felt by the blocking ion and R, T, z, and F have 
their  usual  meanings,  and  using  VDo  values  of  19.7  and  14.2  mV  (Table  I),  we 
calculated that the blocking reaction of QX314 with the ryanodine-unmodified and 
-modified channel had effective valencies (z~) of 1.3 and 1.8, respectively. An effective 
valency of greater than one for a  monovalent cation implies interaction of blocking 
ion with other ions present in the channel (Hille and Schwarz, 1978).  In support of a 
multi-ion pore model that contains more than one ion at a time, the skeletal muscle 
SR Ca  2+ release channel has been suggested to have a rather complex conductance 
pathway. The channel complex has an overall projected dimension of 27  ×  27  x  14 
nm and has been proposed to contain a central channel that connects to four radial 
channels  located  in  the  foot  (cytoplasmic) region  of the  complex  (Wagenknecht, 
Grassucci, Frank, Saito, Inui, and Fleischer,  1989).  The data of this study are most 
readily  explained  by  assuming that  QX314  binds  to  a  site  located  in  a  central, 
ion-conducting pore that is located in the membrane's electric field. In support of 
this suggestion, we found that at low Qx314 concentrations the current fluctuations 
of the  ryanodine-modified channel  could  be  well  resolved  into  open  and  closed 
events (Fig. 8) and described by Eqs. 1, 4-6, and 8 using a Hill coefficient of 1, which 
suggests that QX314 blockade occurred in an all-or-none fashion. 
Ryanodine modifies the SR Ca  2+ release channel by inducing the formation of an 
open, subconducting channel state with about half the unitary Ca  2+ (Rousseau et al., 
1987) and K + (Fig. 7) conductances of the unmodified channel. Since ryanodine also 
decreases the rate constant of glucose effiux from SR vesicles (Meissner,  1986),  it is 
conceivable  that  ryanodine  modification results  in  a  narrowing  of the  channel's 
conductance pathway.  Ryanodine also  profoundly affected the  kinetics  of QX314 
blockade. Zero-voltage blocking and unblocking rates were decreased by factors of 
~ 35  and  7.5,  respectively. Further,  the voltage dependence  of the blocking rate 
increased by a  factor of about two, whereas  that of the unblocking rate was only 
moderately affected, after ryanodine modification. The more pronounced changes of 
ryanodine on  the  blocking rate  led  to  a  decreased  affinity but  increased voltage 
dependence  of the  overall blocking reaction  for the  ryanodine-modified channel. 
Additional studies will be required to more fully characterize the block by QX314 of 
the ryanodine-modified and -unmodified channels. 
Block of Ryanodine-modified Channel by Tetracaine and Procaine 
A blocking action of tetracaine on the Ca2+-gated,  ryanodine-unmodified channel 
could not be demonstrated. One likely reason was that binding of tetracaine to its 
higher affinity regulatory sites reduced channel Po to very low values before single 
channel blockade could have been discerned at the low frequency resolution of the 
bilayer system. A fast procaine block of the ryanodine-unmodified channel occasion- 
ally took  place;  however,  because  of its  infrequent  occurrence  it was  not  further 
studied. 
Ryanodine modification rendered  the SR  Ca  2+  release  channel  less  sensitive to 
inhibition  by  tetracaine  and  procaine.  Under  these  conditions,  a  fast  block  of 
ryanodine-modified channel by the two local anesthetics could be consistently seen. 
In  the  ryanodine-modified  channel,  the  presence  of  high  (> 1  raM)  tetracaine 
concentrations on either or both sides of the bilayer caused asymmetric blocking, Xu ET AL.  SR Ca  z÷ Release Channel and Local Anesthetics  229 
lowering single channel conductance and channel Po for positive holding potentials 
only. The  channel  conductance  and  open  time  were  only  minimally affected  at 
negative potentials.  Since this asymmetry resulted regardless of which side of the 
bilayer the  drug was added  to,  it  is  clear  that  tetracaine  had ready access  to  its 
blocking  site  from  both  sides  of  the  bilayer.  The  voltage-dependent  block  by 
tetracaine could not be well fit to a  simple blocking scheme as described by Eqs.  1 
and 7 in Results. One possible reason was that tetracaine, because of its high lipid 
solubility, could effectively reach the blocking site via a route different from that of 
the conduction pathway, such as the SR membrane composed of phospholipid and 
transmembrane spanning segments of the SR Ca  2+ release channel. Alternatively, it 
was  possible  that  the  modified  channel  underwent  a  conformational change  at 
positive voltages,  such  that the channel could be  physically blocked only at these 
voltages. On the other hand, fast c/s procaine blockade of the ryanodine-modified 
channel could be well described by a  simple blocking scheme. As  summarized in 
Table  I,  zero-voltage blocking and unblocking rates  of procaine were  about  four 
times faster than those of QX314. Another difference was that the unbloc_king rate of 
procaine  appeared  to  be  nearly  voltage  independent,  suggesting  that  the  main 
voltage-dependent  step  of the  blocking  reaction  resided  in  the  blocking  step.  A 
similar  pattern,  with  kb  being  voltage  dependent  but  k-b  being  largely  voltage 
independent,  has  been  reported  for Na + block of the Ca2+-activated  K + channel 
(Yelten, 1984), bis Q10 block of the SR K  + channel (Miller,  1982), and Cs + block of 
the ATP-sensitive K  + channel (Quayle, Standen, and Stanfield, 1988).  These results 
have been explained in terms ofa diffusional limitation of ion flow into the mouth of 
the  channel's  pore  (Yellen,  1984)  and  by  the  formation of a  tight  ion  complex 
between the cationic blocker and a carboxylic group which may have given rise to a 
voltage-independent unbiocking rate  (Moczydlowski,  1986).  It would  appear  that 
neither explanation readily applies  to the SR Ca  2+  release channel since procaine 
binding affinities were low and the drug concentrations used were fairly high. One 
alternative explanation for a  largely voltage-independent unblocking rate would be 
that binding of procaine resulted in the formation of an uncharged molecule. 
Inhibition of SR  Ca  2+ Release by Local Anesawtics 
In earlier studies (see Introduction) it has been proposed  that a  primary target of 
tetracaine and procaine in E-C coupling is a Ca  2+ release pathway in the SR. In two 
recent studies it was mggested that tetracaine, by inhibiting SR Ca  2+ release, affects 
the kitmtics of one of tim components (Qv or hump) of charge movement in skeletal 
mu~te (Szucs et al., 1991; Pizarro et al., 1991). Although concentrations of tetracaine 
as low as 20  and 25  ~M were effective, Szucs et al.  (1991)  also obtained indirect 
evidence that such low concentrations of tetracaine were not sufficient to remove all 
of the  tetracaine-sensitive charge. The  results of this study provide the first more 
direct insights into the mechanism by which local anesthetics may affect E-C coupling 
in skeletal muscle. Our results suggest that tetracaine and procaine reversibly inhibit 
SR Ca  2+ release under different activating conditions by inducing protein conforma- 
tional changes that result in a closing of the SR Ca  2+ release channel. The presence 
of cooperatively interacting drug binding sites leads us to suggest that there may be 
four regulatory drug binding sites per tetrameric Ca  2+ release channel complex (Fig. 230  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  101  •  1993 
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FIGURE 11.  Model  of SR  Ca  2+  re- 
lease channel depicting proposed lo- 
cation of regulatory and blocking sites 
for local anesthetics. Shown is a cross- 
section of the ion conductance path- 
way of the tetrameric SR Ca  ~+ release 
channel composed of a central chan- 
nel  that  may  (Wagenknecht  et  al., 
1989)  or  may  not  be  connected  to 
four  radial  channels  located  in  the 
cytoplasmic portion of the  four  sub- 
units  (only  two  are  shown)  of  the 
channel. The model also indicates (a) 
the  presence  of four  (only two  are  shown)  high-affinity, regulatory binding  sites  for  local 
anesthetics  (I)  in  or near  the  SR  membrane,  and  (b)  a  low-affinity blocking site for  local 
anesthetics  (I--]) which  is  proposed  to  be  located  in  the  central,  transmembrane  spanning 
segment of the ion conductance pathway. 
11).  Cooperative  interactions  within  the  skeletal  muscle  SR  Ca  2+  release  channel 
complex have been previously suggested (a) to explain the appearance of up to four 
equivalent conductance states (Smith et al., 1988; Liu et al., 1989), (b) in studies using 
the  specific channel  ligand ryanodine (Lai,  Misra,  Xu,  Smith,  and  Meissner,  1989), 
and  (c)  by studying the  interaction of the  channel with its three  regulatory ligands 
Ca  2+,  Mg  2+,  and  ATP  (Meissner  et  al.,  1986).  In  addition  to  an  interaction  with 
regulatory sites, local anesthetics  may also inhibit SR Ca  ~+  release by binding to a 
blocking site present within a  centrally located conductance  pathway of the channel 
(Fig.  11). We  suggest  that,  because  of a  lower affinity of the blocking site, the  two 
local anesthetics  tetracaine  and  procaine  primarily inhibit the  release of Ca  2+  ions 
from SR in muscle by an allosteric rather than a  direct blocking mechanism. 
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